Regulatory cell therapy in kidney transplantation (The ONE Study): A harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials

<p><strong>Background:</strong><br /> Use of cell-based medicinal products (CBMPs) represents a state-of-the-art approach for reducing general immunosuppression in organ transplantation. We tested multiple regulatory CBMPs in kidney transplant trials to establish the safety o...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Sawitzki, B, Harden, PN, Reinke, P, Hester, JL, Issa, F, Morris, PJ, Bushell, A, Friend, PJ, Wood, KJ
Materialtyp: Journal article
Språk:English
Publicerad: Elsevier 2020